Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
197 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05520372 | Autologous Immune Enhancement Therapy (AIET) for Cancer Patients | completed | Phase 1 | 60 | Vinmec Research Institute of Stem Cell and Gene TechnologyOTHER | 1 | Aug 29, 2022 | clinicaltrials |
| NCT05498168 | Computational Prediction and Experimental Validation of Esophageal Cancer Associated Neoantigens | unknown | — | 50 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Aug 11, 2022 |
| clinicaltrials |
| NCT05498194 | Computational Prediction and Experimental Validation of Gastric Cancer Associated Neoantigens | unknown | — | 50 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT03476018 | Trial to Optimally Show the Pharmacological Action of Z-100 | completed | Phase 3 | 72 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 16, 2022 | clinicaltrials |
| NCT05027347 | Detection of Plasma Circulating Tumor DNA in Gastric Cancer | unknown | — | 200 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05061082 | Genomic Evolution of Metastasis in Gastric Cancer | unknown | — | 20 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05342805 | Comparison of Subtotal Stomach and Narrow Gastric Tube After Esophagectomy | unknown | N/A | 50 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05301530 | Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients. | completed | Phase 1 | 50 | Nanogen Pharmaceutical Biotechnology Joint Stock CompanyINDUSTRY | 1 | Mar 29, 2022 | clinicaltrials |
| NCT04633564 | MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC | completed | Phase 3 | 671 | Mylan Pharmaceuticals IncINDUSTRY | 17 | Mar 16, 2022 | clinicaltrials |
| NCT03931980 | Robotic Versus Laparoscopic Approach for Rectal Cancer Surgery | completed | N/A | 100 | Binh Dan HospitalOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT02810457 | Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer(AVANA) | completed | Phase 3 | 731 | Centus Biotherapeutics LimitedINDUSTRY | 24 | Mar 10, 2022 | clinicaltrials |
| NCT02247232 | Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer | completed | Phase 3 | 793 | Zeria PharmaceuticalINDUSTRY | 7 | Mar 4, 2022 | clinicaltrials |
| NCT05103488 | Comprehensive Palliative Care for Cancer Patients in Vietnam | completed | N/A | 100 | Vietnam Palliative Health Care SocietyOTHER | 1 | Nov 2, 2021 | clinicaltrials |
| NCT02551159 | Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer(KESTREL) | completed | Phase 3 | 823 | AstraZenecaINDUSTRY | 23 | Oct 13, 2021 | clinicaltrials |
| NCT01566721 | A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(SafeHER) | completed | Phase 3 | 2,577 | Hoffmann-La RocheINDUSTRY | 59 | Apr 27, 2021 | clinicaltrials |
| NCT02788214 | Helicobacter Pylori Genome Project (HpGP) | terminated | — | 1,000 | National Cancer Institute (NCI)NIH | 53 | Dec 19, 2020 | clinicaltrials |
| NCT04666376 | Assessing the Technique of Ovarian Tissue Cryopreservation by Vitrification in Vietnam | unknown | N/A | 43 | Mỹ Đức HospitalOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04520386 | OMT-111 for Terminal Stage Solid Tumors | unknown | Phase 2 | 78 | MetiMedi PharmaceuticalsINDUSTRY | 1 | Sep 9, 2020 | clinicaltrials |
| NCT04386343 | CH1701 for Prevention and Treatment of Radiation Burns(CH1701) | unknown | Phase 1 / Phase 2 | 92 | Vietlife Healthcare CorporationOTHER_GOV | 1 | Aug 24, 2020 | clinicaltrials |
| NCT04011865 | Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer Treatment | unknown | N/A | 80 | Binh Dan HospitalOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT04132349 | Ulipristal Acetate in Symptomatic Uterine Fibroid | terminated | Phase 4 | 25 | Mỹ Đức HospitalOTHER | 1 | Apr 13, 2020 | clinicaltrials |
| NCT03176238 | Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer(EVEREXES) | completed | Phase 3 | 235 | Novartis PharmaceuticalsINDUSTRY | 13 | Apr 7, 2020 | clinicaltrials |
| NCT03546842 | Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) | completed | Phase 3 | 201 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Feb 25, 2020 | clinicaltrials |
| NCT02272413 | Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer | completed | Phase 3 | 671 | Boehringer IngelheimINDUSTRY | 28 | Jan 13, 2020 | clinicaltrials |
| NCT01561586 | Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer(TACO) | unknown | Phase 3 | 374 | Korea Cancer Center HospitalOTHER | 4 | Feb 27, 2019 | clinicaltrials |
| NCT03823456 | Self-acupressure for Cancer-related Symptom Cluster of Insomnia, Depression, and Anxiety: a Feasibility Study | unknown | N/A | 114 | The Hong Kong Polytechnic UniversityOTHER | 1 | Feb 1, 2019 | clinicaltrials |
| NCT01933945 | Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib(OPTIMIS) | completed | — | 1,676 | BayerINDUSTRY | 31 | Nov 6, 2018 | clinicaltrials |
| NCT03504618 | Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI | completed | — | 39 | Hanoi Medical UniversityOTHER | 1 | Apr 20, 2018 | clinicaltrials |
| NCT01724021 | A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a | completed | Phase 3 | 743 | Hoffmann-La RocheINDUSTRY | 32 | Jan 23, 2018 | clinicaltrials |
| NCT03093129 | Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)(NeoART-V) | unknown | Phase 2 | 200 | The 108 Military Central HospitalOTHER_GOV | 1 | Jan 9, 2018 | clinicaltrials |
| NCT03381417 | Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients. | completed | Phase 3 | 128 | Nanogen Pharmaceutical Biotechnology Joint Stock CompanyINDUSTRY | 1 | Jan 2, 2018 | clinicaltrials |
| NCT03376503 | Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients | completed | Phase 1 | 24 | Nanogen Pharmaceutical Biotechnology Joint Stock CompanyINDUSTRY | 1 | Dec 19, 2017 | clinicaltrials |
| NCT03332199 | A Psycho-educational Intervention for Symptom Cluster Management | completed | N/A | 102 | Hanoi Medical UniversityOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT03267407 | Vietnam Cryptococcal Retention in Care Study - Version 2.1 | unknown | — | 1,184 | National Hospital for Tropical Diseases, Hanoi, VietnamOTHER_GOV | 1 | Sep 12, 2017 | clinicaltrials |
| NCT00384176 | First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX(HORIZON III) | completed | Phase 2 / Phase 3 | 1,814 | AstraZenecaINDUSTRY | 28 | Apr 14, 2017 | clinicaltrials |
| NCT00524745 | Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil | completed | N/A | 903 | PATHOTHER | 1 | Apr 14, 2017 | clinicaltrials |
| NCT00812175 | Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib(GIDEON) | completed | — | 3,371 | BayerINDUSTRY | 39 | Oct 17, 2016 | clinicaltrials |
| NCT00312377 | ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer(ZODIAC) | completed | Phase 3 | 1,690 | Genzyme, a Sanofi CompanyINDUSTRY | 25 | Sep 30, 2016 | clinicaltrials |
| NCT00293540 | Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer | completed | Phase 3 | 249 | International Breast Cancer Research FoundationOTHER | 10 | Jul 27, 2016 | clinicaltrials |
| NCT01584830 | Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy(CONCUR) | completed | Phase 3 | 204 | BayerINDUSTRY | 5 | Feb 8, 2016 | clinicaltrials |
| NCT00201851 | Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | completed | Phase 3 | 740 | International Breast Cancer Research FoundationOTHER | 3 | Apr 29, 2015 | clinicaltrials |
| NCT00041275 | Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 300 | National Medical Research Council (NMRC), SingaporeOTHER_GOV | 10 | Sep 20, 2013 | clinicaltrials |
| NCT01185314 | To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)(PIONEER) | completed | N/A | 1,270 | AstraZenecaINDUSTRY | 7 | Aug 8, 2011 | clinicaltrials |
| NCT00737009 | An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment | completed | — | 259 | AstraZenecaINDUSTRY | 1 | Jun 22, 2011 | clinicaltrials |
| NCT01018381 | Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection | completed | N/A | 130 | The 108 Military Central HospitalOTHER_GOV | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00572000 | Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule(HPV-022 PRI) | unknown | N/A | 222 | National Institute for Control of Vaccine and BiologicalsOTHER_GOV | 1 | Dec 12, 2007 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials